Clinical Trial Update: MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating magnesium to prevent HIOC-associated acute kidney injury is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Mesothelioma | Phase 2 | Status: RECRUITING